Drugs / Influenza virus vaccine (CAIV-T)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00001127 | ? → Nov 2005 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza virus vaccine (CAIV-T) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001127 ↗ |
| Modality | Vaccine | “flu vaccine” NCT00001127 ↗ |
| Route | Intranasal | “given by a nasal spray” NCT00001127 ↗ |